Marshfield Clinic Research Foundation
15
2
2
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.7%
1 terminated/withdrawn out of 15 trials
90.0%
+3.5% vs industry average
13%
2 trials in Phase 3/4
44%
4 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Open-Label Influenza Vaccine Evaluation
Role: lead
Randomized Influenza Vaccine Evaluation of Immune Response
Role: lead
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Role: collaborator
The Baby Act Trial (BAT): a Multimodal Lifestyle Intervention
Role: collaborator
COVID-19 Booster Dose Reminder/Recall for Adolescents
Role: lead
Clinical Registry Investigating Bardet-Biedl Syndrome
Role: lead
Correlation Between Oral Health and Systemic Inflammation (COHESION)
Role: lead
Efficacy Study of Early Versus Late Oseltamivir Administration for Treating and Preventing Influenza
Role: lead
Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents
Role: lead
Inguinal Hernia Management: Watchful Waiting vs. Tension-Free Open Repair
Role: collaborator
Electronic Tool for Interaction Between Patients and Health Professionals
Role: collaborator
Bilateral Transforaminal Epidural Steroid Injections for Degenerative Lumbar Spinal Stenosis
Role: lead
Creating Healthy Work Places (HWP) Study
Role: collaborator
Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling Adults
Role: collaborator
Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing
Role: collaborator
All 15 trials loaded